On July 7th 2017, more than 4500 runners participated in the 2,7 kilometer circuit, the 11-kilometer distance or the half marathon, “21-kilometers against cancer”. About 300 local teams participated. 114.000 Euros had been raised on Friday. By now the fundraising goal of 125.000 Euro has been achieved through revenues of the food and beverage –sale, as well as further donations. The proceedings of the 6th charity run will be contributed to innovative projects of cancer research at the National Center for Tumor Diseases (NCT) in Heidelberg.
The NCT Heidelberg is a joint institution of the German Cancer Research Center (DKFZ), the Heidelberg University Hospital and the German Cancer Aid.
“I am running to set an example against cancer together with others and because I am thankful for being healed”. This was one of many reasons runners had sent the organizing committee of the NCT-run. Children, students, patients, relatives, employees and long-distance specialists gathered on July 7th 2017 at the NCT to support the NCT-charity run. More than 1200 runners took off for the 11-kilometer distance at 6pm. Ten minutes later the starting signal for 785 participants, who trained for the half marathon, went off. At 6.20pm, 2545 runners got underway on the 2,7 kilometer circuit through the Neuenheimer Feld.
Many local companies and teams participated to motivate friends and relatives with cancer to keep fighting. SAP and Roche provided the biggest teams. Roche supported the NCT with an amount of 2,50 Euro for each round of the circuit through the Neuenheimer Feld. The maximum sponsoring sum of 13.000 Euro was reached thanks to the very committed runners.
“The weather forecast remained unpredictable. The announced thunderstorms luckily did not happen. With the NCT-run we want to counter cancer with positivity – something the many runners certainly achieved again this year despite the very warm temperatures, as Professor Christoph von Kalle, Managing Director of the NCT Heidelberg, reports. Through the support of all participants we can further engage into innovative research projects at the NCT in the following years. Thank you for your support!”
On Friday, the fundraising goal of 125.000 Euro was almost reached, with 114.000 Euro from registration fees and the donations of sponsors. “Additional donations over the weekend as well as the revenue from the food and beverage sale now led to achieving our fundraising goal”, reports Jörg Fleckenstein happily, Head of Strategic Planning at the NCT. The final fundraising result will be announced on www.nct-lauf.de in the following days.
A special thanks goes to the 180 helpers who created and secured the event. The band “The Wright Thing” provided musical entertainment during and after the run. The sport-event was moderated and guided by Tom Haberer.
Facts and Figures:
Fundraising goal: 125.000 Euro
Proceeds: Friday July 7th: 114.000 Euro – entailing company-sponsoring. Thanks to additional donations, food and beverage-sale the fundraising goal of 125.000 Euro has been achieved. Final results will be announced on www.nct-lauf.de in the course of this week.
Participants: 4506 (2545 circuit, 1203 11-kilometers, 758 half marathon)
Number of Teams: 381
Number of raced rounds (2, 7 kilometer circuit): 7583
Distance Circuit: 2,7 kilometer circuit, flat, no traffic
Distance 11-km: Agricultural roads toward Ladenburg turn close to Dossenheimer Schleuse
Distance half marathon: Streets and paths toward Ladenburg, via Schwabenheimer Hof
back to the NCT along the Neckar
Start and finish: Im Neuenheimer Feld 460, in front of the NCT, also start of the half marathon and 11-kilometer-distance
Catering: International specialties, also vegan and vegetarian, beverages
Music: The Wright Thing
Moderation: Tom Haberer
Sponsors and partners: Roche, SAP, Sparkasse Heidelberg, Stadtwerke Heidelberg, haessmedia
Catering Partner: Heidelberger Schloss, Serai, Pretty Burger, LoveFood, Klosterhof Heidelberg, HeldenPause
Dr. Friederike Fellenberg
Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg
Press and Public Relations
Im Neuenheimer Feld 460
Tel.: +49 6221 56-5930
Fax: +49 6221 56-5350
Dr. Sybille Kohlstädt
Head of Press and Public Relations
German Cancer Research Center
Im Neuenheimer Feld 280
T: +49 6221 42 2843
F: +49 6221 42 2968
Universitätsklinikum Heidelberg und Medizinische Fakultät der Universität Heidelberg
Press Officer and Head of Press and Public Relations
Im Neuenheimer Feld 672
Tel.: +49 6221 56-5052
Fax: +49 6221 56-4544
The National Center for Tumor Diseases (NCT) Heidelberg
The National Center for Tumor Diseases (NCT) Heidelberg is a joint institution of the German Cancer Research Center, Heidelberg University Hospital and German Cancer Aid. The NCT's goal is to link promising approaches from cancer research with patient care from diagnosis to treatment, aftercare and prevention. The interdisciplinary tumor outpatient clinic is the central element of the NCT. Here the patients benefit from an individual treatment plan prepared in a timely manner in interdisciplinary expert rounds, the so-called tumor boards. Participation in clinical studies provides access to innovative therapies. The NCT thereby acts as a pioneering platform that translates novel research results from the laboratory into clinical practice. The NCT cooperates with self-help groups and supports them in their work. 2015 the NCT Heidelberg established a partner location in Dresden.
The German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)
The German Cancer Research Center (DKFZ) with its more than 3,000 employees is the largest biomedical research institute in Germany. At DKFZ, more than 1,000 scientists investigate how cancer develops, identify cancer risk factors and endeavor to find new strategies to prevent people from getting cancer. They develop novel approaches to make tumor diagnosis more precise and treatment of cancer patients more successful. The staff of the Cancer Information Service (KID) offers information about the widespread disease of cancer for patients, their families, and the general public. Jointly with Heidelberg University Hospital, DKFZ has established the National Center for Tumor Diseases (NCT) Heidelberg, where promising approaches from cancer research are translated into the clinic. In the German Consortium for Translational Cancer Research (DKTK), one of six German Centers for Health Research, DKFZ maintains translational centers at seven university partnering sites. Combining excellent university hospitals with high-profile research at a Helmholtz Center is an important contribution to improving the chances of cancer patients. DKFZ is a member of the Helmholtz Association of National Research Centers, with ninety percent of its funding coming from the German Federal Ministry of Education and Research and the remaining ten percent from the State of Baden-Württemberg.
Heidelberg University Hospital and Medical Faculty Heidelberg
Health care, research and teaching of international standing
Heidelberg University Hospital is one of the most important medical centers in Germany; Heidelberg University's Medical Faculty is one of Europe's most prestigious biomedical research facilities. Their shared objective is the development of innovative diagnostics and treatments and their prompt implementation for the benefit of the patient. The hospital and faculty employ approximately 12 600 individuals and are involved in training and qualification. Every year approximately 66 000 patients are treated as inpatients or day patients in more than 50 specialized clinical departments with about 1 900 beds, with more than 1 million patients being treated as outpatients. The Heidelberg Curriculum Medicinale (HeiCuMed) is at the forefront of medical training in Germany. At present approx. 3500 prospective physicians are studying in Heidelberg.